“including safety pharmacology studies, repeat-dose toxicity studies in mice and monkeys for durations up to 4 and 26 weeks, respectively, reproductive toxicity studies in mice and rabbits”
Functional lectin-pathway inhibition in mouse, rabbit and cynomolgus monkey (3.8-, 2.7-, 10-fold less potent than human); none in rat
“OMS721 displayed functional activity in mouse, rabbit, and cynomolgus monkey, with potencies 3.8, 2.7 and 10-fold less than human. No functional activity was observed in rats.”
No surrogate; the clinical antibody was tested in mice, monkeys and rabbits
“including safety pharmacology studies, repeat-dose toxicity studies in mice and monkeys for durations up to 4 and 26 weeks, respectively, reproductive toxicity studies in mice and rabbits”